ALBANY, N.Y.--(BUSINESS WIRE)--
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally
invasive medical devices for vascular access and the treatment of
peripheral vascular disease and cancer, today announced that it will
report its fiscal 2011 third quarter financial results on Tuesday, April
5, 2011, after the close of the U.S. financial markets.
Jan Keltjens, President and Chief Executive Officer, and Joseph Gersuk,
Executive Vice President and Chief Financial Officer, will host an
investment community conference call beginning at 4:30 p.m. Eastern Time
on April 5, 2011, to discuss the quarter's results and to answer
questions.
To participate in the live call by telephone, please dial +1 (877)
941-6009.
Those interested in listening to the conference call live via the
Internet may do so by visiting the Investor Relations section of
AngioDynamics' Web site at http://investors.angiodynamics.com.
To listen to the live call, please go to the Web site 15 minutes prior
to its start to register, download and install the necessary audio
software. The conference call will also be archived on the Web site.
About AngioDynamics
AngioDynamics, Inc. is a leading provider of innovative, minimally
invasive medical devices used by professional healthcare providers for
vascular access and the treatment of peripheral vascular disease and
cancer. AngioDynamics' diverse product lines include market-leading
ablation systems, vascular access products, angiographic products and
accessories, angioplasty products, drainage products, thrombolytic
products, embolization products and venous products. More information is
available at www.angiodynamics.com.
Company Contact:
AngioDynamics, Inc.
D.
Joseph Gersuk, CFO, 800-772-6446 ext. 1608
jgersuk@AngioDynamics.com
or
Investor
Relations Contacts:
EVC Group, Inc.
Doug
Sherk/ Greg Gin
415-896-6820
dsherk@evcgroup.com
ggin@evcgroup.com
or
Media
Contact:
EVC Group, Inc.
Chris Gale,
646-201-5431
cgale@evcgroup.com
Source: AngioDynamics, Inc.
News Provided by Acquire Media